| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.27 | 4e-12 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.26 | 4e-12 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-12 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.27 | 1e-11 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.25 | 2e-11 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-11 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.24 | 2e-11 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.28 | 2e-11 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.27 | 3e-11 |